Insiders · HOWL

HOWL insider transactions

Werewolf Therapeutics Inc. (HOWL) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for HOWL

• 43d
  New insider Urban Michael J. claimed ownership of 5,284 shares (SEC Form 3)

  3 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 95d
  Director Evnin Luke sold $20,942 worth of shares (38,782 units at $0.54) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 100d
  Director Evnin Luke sold $61,787 worth of shares (111,227 units at $0.56) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 103d
  Director Evnin Luke sold $53,533 worth of shares (91,374 units at $0.59) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 108d
  Director Evnin Luke sold $45,882 worth of shares (71,054 units at $0.65) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 113d
  Director Evnin Luke sold $48,431 worth of shares (78,377 units at $0.62) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 117d
  Director Evnin Luke sold $185,221 worth of shares (291,283 units at $0.64) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 129d
  Director Evnin Luke sold $51,951 worth of shares (48,171 units at $1.08) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 134d
  Director Evnin Luke sold $88,587 worth of shares (82,971 units at $1.07) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 137d
  Director Evnin Luke sold $94,787 worth of shares (95,179 units at $1.00) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 142d
  Director Evnin Luke sold $117,623 worth of shares (128,185 units at $0.92) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 142d
  Former 10% Owner Mpm Bioventures 2014, L.P. sold $183,275 worth of shares (199,732 units at $0.92) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 142d
  Former 10% Owner Gadicke Ansbert sold $183,275 worth of shares (199,732 units at $0.92) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 145d
  Director Evnin Luke sold $87,833 worth of shares (91,088 units at $0.96) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 145d
  Large owner Mpm Bioventures 2014, L.P. sold $136,855 worth of shares (141,927 units at $0.96) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 145d
  SEC Form 4 filed by Werewolf Therapeutics Inc.

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 151d
  Director Evnin Luke sold $115,234 worth of shares (125,576 units at $0.92) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 151d
  Large owner Mpm Bioventures 2014, L.P. sold $179,551 worth of shares (195,666 units at $0.92) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 151d
  Large owner Gadicke Ansbert sold $179,551 worth of shares (195,666 units at $0.92) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 156d
  Director Evnin Luke sold $94,930 worth of shares (102,753 units at $0.92) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 156d
  Large owner Mpm Bioventures 2014, L.P. sold $147,913 worth of shares (160,103 units at $0.92) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 156d
  Large owner Gadicke Ansbert sold $147,913 worth of shares (160,103 units at $0.92) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 159d
  Director Evnin Luke sold $128,785 worth of shares (134,553 units at $0.96) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 159d
  Large owner Mpm Bioventures 2014, L.P. sold $200,665 worth of shares (209,652 units at $0.96) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 159d
  Large owner Gadicke Ansbert sold $200,665 worth of shares (209,652 units at $0.96) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 164d
  Director Evnin Luke sold $154,850 worth of shares (137,041 units at $1.13) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 164d
  Large owner Mpm Bioventures 2014, L.P. sold $241,278 worth of shares (213,529 units at $1.13) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 164d
  Large owner Gadicke Ansbert sold $241,278 worth of shares (213,529 units at $1.13) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 170d
  Director Evnin Luke sold $189,830 worth of shares (155,885 units at $1.22) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 170d
  Large owner Mpm Bioventures 2014, L.P. sold $295,781 worth of shares (242,890 units at $1.22) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 170d
  Large owner Gadicke Ansbert sold $295,781 worth of shares (242,890 units at $1.22) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 173d
  Director Evnin Luke sold $251,349 worth of shares (189,356 units at $1.33) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 173d
  Large owner Mpm Bioventures 2014, L.P. sold $391,636 worth of shares (295,043 units at $1.33) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 173d
  Large owner Gadicke Ansbert sold $391,636 worth of shares (295,043 units at $1.33) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 178d
  Director Evnin Luke sold $286,497 worth of shares (177,145 units at $1.62) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 178d
  Large owner Mpm Bioventures 2014, L.P. sold $446,403 worth of shares (276,017 units at $1.62) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 178d
  Large owner Gadicke Ansbert sold $446,403 worth of shares (276,017 units at $1.62) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 316d
  SEC Form 4 filed by Director Evnin Luke

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 316d
  SEC Form 4 filed by Director Morrison Briggs

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 316d
  SEC Form 4 filed by Director Lazarus Alon

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 316d
  SEC Form 4 filed by Director Chatterjee Meeta

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 316d
  SEC Form 4 filed by Director Atkins Michael B.

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 316d
  SEC Form 4 filed by Director Sherman Michael A.

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 316d
  SEC Form 4 filed by Director Singhal Anil K.

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 346d
  Director Ra Capital Management, L.P. bought $487,188 worth of shares (536,426 units at $0.91) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 358d
  SEC Form 4 filed by Chief Business Officer Bloom Steven H.

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 360d
  Large owner Mpm Bioventures 2014, L.P. exercised 22,758 in-the-money shares at a strike of $0.09 and sold $2,061 worth of shares (1,963 units at $1.05) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 360d
  Director Evnin Luke exercised 28,113 in-the-money shares at a strike of $0.09 and sold $2,546 worth of shares (2,425 units at $1.05) (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 360d
  Large owner Gadicke Ansbert sold $4,605 worth of shares (4,386 units at $1.05) and exercised 50,873 in-the-money shares at a strike of $0.09 (SEC Form 4)

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 372d
  SEC Form 3 filed by new insider Bloom Steven H.

  3 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 428d
  SEC Form 4 filed by Director Singhal Anil K.

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 428d
  SEC Form 3 filed by new insider Singhal Anil K.

  3 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 474d
  SEC Form 4 filed by Chief Business Officer Lubman Ellen

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 474d
  SEC Form 4 filed by Chief Financial Officer Trost Timothy W.

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 474d
  SEC Form 4 filed by Chief Medical Officer Isaacs Randi

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 474d
  SEC Form 4 filed by Chief Technology Officer Karunatilake Chulani

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 474d
  SEC Form 4 filed by Officer Hicklin Daniel J

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 701d
  SEC Form 4 filed by Ra Capital Management, L.P.

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 701d
  SEC Form 4 filed by Dirocco Derek

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)
• 701d
  SEC Form 4 filed by Morrison Briggs

  4 - Werewolf Therapeutics, Inc. (0001785530) (Issuer)